These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23259835)

  • 41. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy.
    Aquaro GD; Positano V; Pingitore A; Strata E; Di Bella G; Formisano F; Spirito P; Lombardi M
    J Cardiovasc Magn Reson; 2010 Apr; 12(1):21. PubMed ID: 20374627
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Left ventricular short-axis systolic function changes in patients with hypertrophic cardiomyopathy detected by two-dimensional speckle tracking imaging.
    Huang J; Yan ZN; Rui YF; Fan L; Liu C; Li J
    BMC Cardiovasc Disord; 2018 Jan; 18(1):13. PubMed ID: 29378516
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
    Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Accelerating Cardiac Diffusion Tensor Imaging With a U-Net Based Model: Toward Single Breath-Hold.
    Ferreira PF; Banerjee A; Scott AD; Khalique Z; Yang G; Rajakulasingam R; Dwornik M; De Silva R; Pennell DJ; Firmin DN; Nielles-Vallespin S
    J Magn Reson Imaging; 2022 Dec; 56(6):1691-1704. PubMed ID: 35460138
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.
    Moravsky G; Ofek E; Rakowski H; Butany J; Williams L; Ralph-Edwards A; Wintersperger BJ; Crean A
    JACC Cardiovasc Imaging; 2013 May; 6(5):587-96. PubMed ID: 23582356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 4D flow MRI and T1 -Mapping: Assessment of altered cardiac hemodynamics and extracellular volume fraction in hypertrophic cardiomyopathy.
    van Ooij P; Allen BD; Contaldi C; Garcia J; Collins J; Carr J; Choudhury L; Bonow RO; Barker AJ; Markl M
    J Magn Reson Imaging; 2016 Jan; 43(1):107-14. PubMed ID: 26227419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo diffusion-tensor MRI of the human heart on a 3 tesla clinical scanner: An optimized second order (M2) motion compensated diffusion-preparation approach.
    Nguyen C; Fan Z; Xie Y; Pang J; Speier P; Bi X; Kobashigawa J; Li D
    Magn Reson Med; 2016 Nov; 76(5):1354-1363. PubMed ID: 27550078
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T1 mapping in children and young adults with hypertrophic cardiomyopathy.
    Parekh K; Markl M; Deng J; de Freitas RA; Rigsby CK
    Int J Cardiovasc Imaging; 2017 Jan; 33(1):109-117. PubMed ID: 27659477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diffusion Tensor Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.
    Khalique Z; Ferreira PF; Scott AD; Nielles-Vallespin S; Martinez-Naharro A; Fontana M; Hawkins P; Firmin DN; Pennell DJ
    Circ Cardiovasc Imaging; 2020 May; 13(5):e009901. PubMed ID: 32408830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coronary microvascular ischemia in hypertrophic cardiomyopathy - a pixel-wise quantitative cardiovascular magnetic resonance perfusion study.
    Ismail TF; Hsu LY; Greve AM; Gonçalves C; Jabbour A; Gulati A; Hewins B; Mistry N; Wage R; Roughton M; Ferreira PF; Gatehouse P; Firmin D; O'Hanlon R; Pennell DJ; Prasad SK; Arai AE
    J Cardiovasc Magn Reson; 2014 Aug; 16(1):49. PubMed ID: 25160568
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Geometric assessment of asymmetric septal hypertrophic cardiomyopathy by CMR.
    Florian A; Masci PG; De Buck S; Aquaro GD; Claus P; Todiere G; Van Cleemput J; Lombardi M; Bogaert J
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):702-11. PubMed ID: 22789938
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myocardial Stiffness Evaluation Using Noninvasive Shear Wave Imaging in Healthy and Hypertrophic Cardiomyopathic Adults.
    Villemain O; Correia M; Mousseaux E; Baranger J; Zarka S; Podetti I; Soulat G; Damy T; Hagège A; Tanter M; Pernot M; Messas E
    JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1135-1145. PubMed ID: 29550319
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relation between left ventricular outflow tract obstruction and left ventricular shape in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
    Martin R; Lairez O; Boudou N; Méjean S; Lhermusier T; Dumonteil N; Berry M; Cognet T; Massabuau P; Elbaz M; Rousseau H; Galinier M; Carrié D
    Arch Cardiovasc Dis; 2013; 106(8-9):440-7. PubMed ID: 23906680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short-Term Repeatability of in Vivo Cardiac Intravoxel Incoherent Motion Tensor Imaging in Healthy Human Volunteers.
    Zhang XS; Liu EH; Wang XY; Zhou XX; Zhang HX; Zhu YM; Sang XQ; Kuai ZX
    J Magn Reson Imaging; 2022 Mar; 55(3):854-865. PubMed ID: 34296813
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantification of left atrial function in patients with non-obstructive hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking imaging: a feasibility and reproducibility study.
    Yang Y; Yin G; Jiang Y; Song L; Zhao S; Lu M
    J Cardiovasc Magn Reson; 2020 Jan; 22(1):1. PubMed ID: 31898543
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early segmental relaxation abnormalities in hypertrophic cardiomyopathy for differential diagnostic of patients with left ventricular hypertrophy.
    Voigt C; Münch J; Avanesov M; Suling A; Witzel K; Lund G; Patten M
    Clin Cardiol; 2017 Nov; 40(11):1026-1032. PubMed ID: 28741295
    [TBL] [Abstract][Full Text] [Related]  

  • 57. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
    Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myocardial fibrosis and quality of life in patients with non-ischemic cardiomyopathy: a cardiovascular magnetic resonance imaging study.
    Khan R; Massel D; Stirrat J; Scholl D; Wisenberg G; Thompson T; Drangova M; White JA
    Int J Cardiovasc Imaging; 2013 Feb; 29(2):395-404. PubMed ID: 22875171
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advanced myocardial characterization in hypertrophic cardiomyopathy: feasibility of CMR-based feature tracking strain analysis in a case-control study.
    Yang L; Zhang L; Cao S; Gao C; Xu H; Song T; Zhang X; Wang K
    Eur Radiol; 2020 Nov; 30(11):6118-6128. PubMed ID: 32588208
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diffusion tensor cardiovascular magnetic resonance with a spiral trajectory: An in vivo comparison of echo planar and spiral stimulated echo sequences.
    Gorodezky M; Scott AD; Ferreira PF; Nielles-Vallespin S; Pennell DJ; Firmin DN
    Magn Reson Med; 2018 Aug; 80(2):648-654. PubMed ID: 29266435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.